RHONDA GILBERT: Open Payments
NPI 1245767128 · CALHOUN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,460 in 94 payments from 17 companies in 2025. Trend: 2023 $1,005 · 2024 $1,335 · 2025 $1,460
Food & beverage: $1,460
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $337 |
| PFIZER INC. | 16 | $298 |
| Novo Nordisk Inc | 11 | $214 |
| Lilly USA, LLC | 8 | $148 |
| GlaxoSmithKline, LLC. | 5 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Amgen Inc. | 3 | $43 |
| Abbott Laboratories | 2 | $39 |
| Xeris Pharmaceuticals, Inc. | 2 | $29 |
Products named: QULIPTA, ELIQUIS, VRAYLAR, Ozempic, NURTEC ODT, TRELEGY ELLIPTA, Wegovy, PREVNAR 20.
Industry payments across GA — which companies pay providers there.
